989
Views
21
CrossRef citations to date
0
Altmetric
Original Articles

Using Tolerance Intervals for Assessment of Pharmaceutical Quality

, , &
Pages 317-327 | Received 29 Sep 2014, Accepted 30 Sep 2014, Published online: 25 Feb 2015

REFERENCES

  • Berger, R. L., Hsu, J. C. (1996). Bioequivalence trials, intersection-union tests and equivalence confidence sets. Statistical Science. 11:283–319.
  • Boos, D., Hoffman, D., Kringle, R., Zhang, J. (2007). New confidence bounds for QT studies. Statistics in Medicine 26:3801–3817.
  • Dong, X., Tsong, Y. (2014). Equivalence assessment for interchangeability based on two-sided tests. Journal of Biopharmaceutical Statistics 24:1312–1331.
  • Dong, X., Tsong, Y., Shen, M. (2014). Equivalence Tests for Interchangeability Based on Two One-Sided Probabilities. Journal of Biopharmaceutical Statistics 24:1332–1348.
  • Hauck, W. W., Foster. T., Sheinin, E., Cecil, T., Brown, W., Marques, M., Williams, R. L. (2005). Oral dosage form performance tests: New dissolution approaches. Pharmaceutical Research 22:182–187.
  • Hauck, W. W., Shalkh, R. (2004). Modified two-sided normal tolerance intervals for batch acceptance of dose uniformity. Pharmaceutical Statistics 3:89–97.
  • Mathew, T., Krishnamoorthy, K. (2009). Statistical Tolerance Regions: Theory, Applications, and Computations. Hoboken, NJ: John Wiley & Sons.
  • Novick, S., Christopher, D., Dey, M., Lyapustina, S., Golden, M., Leiner, S., Wyka, B., Delzeit, H-J., Novak, C., Larner, G. (2009). A two one-sided parametric tolerance interval test for control of delivered dose uniformity. Part I – characterization of FDA proposed test. AAPS PharmSciTech, 10:820–826.
  • The Japanese Pharmacopoeia, JPXIV. (2001). 14th ed. The Society of Japanese Pharmacopoeia, p. 25.
  • Tse, S.-K., Chang, J.-Y., Su, W.-L., Chow, S.-C., Hsiung, C., Lu, Q. (2006). Statistical quality control process for traditional Chinese medicine. Journal of Biopharmaceutical Statistics. 7:41–48.
  • Tsong, Y., Dong, X., Shen, M., Lostritto, T. T. (2015). Quality assurance test of delivery dose uniformity of multiple-dose inhaler and dry powder inhaler drug products. Journal of Biopharmaceutical Statistics 25:328–339.
  • Tsong, Y., Shen, M. (2007). Parametric two-stage sequential quality assurance test of dose content uniformity. Journal of Biopharmaceutical Statistics. 17:143–157.
  • Tsong, Y., Shen, M., Lostritto, R. T. (2008). Parametric two-tier sequential quality assurance test of delivery dose uniformity of multiple-dose inhaler and dry powder inhaler drug products. Journal of Biopharmaceutical Statistics. 18:976–984.
  • Tsong, Y., Shen, M., Shah, V.P. (2004). Three-stage sequential dissolution testing rules. Journal of Biopharmaceutical Statistics. 14:757–779.
  • Tsong, Y., Zhong, J. (2010). Multiple comparisons of repeated measured responses: Issues of assessment of prolongation of QTc interval. Journal of Biopharmaceutical Statistics. 20:613–623.
  • Wald, A. (1943). An extension of Wilks’s method for setting tolerance limits. Annals of Mathematical Statistics 13:45–55.
  • Wilks, S. S. (1941). Determination of sample sizes for setting tolerance-limit factors for normal distribution. Annals of Mathematical Statistics, 12:91–96.
  • Wilks, S. S. (1942). Statistical prediction with special reference to the problem of tolerance limits. Annals of Mathematical Statistics, 13:400–409.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.